课题基金 / 基金详情

SPECT-CT Guided ELEctive Contralateral Neck Treatment (SELECT) for Patients with Lateralized Oropharyngeal Cancer: A Phase III Randomized Controlled Trial

SPECT-CT Guided ELEctive Contralateral Neck Treatment (SELECT) for Patients with Lateralized Oropharyngeal Cancer: A Phase III Randomized Controlled Trial
SPECT-CT 引导偏侧性口咽癌患者的选择性对侧颈部治疗 (SELECT)：一项 III 期随机对照试验
批准号：
433307
负责人：
Parulekar Wendy R
金额：
$233.37万
依托单位：
Queen's University (Kingston, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2020
资助国家：
加拿大
项目状态：
未结题
起止时间：
2020-10-01 至 2028-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=433307&lang=en
关键词：
Cost Utility De-Intestification Image-Guided Treatment Lymphatic Mapping Oropharyngeal Cancer Quality Of Life Spect-Ct Volume De-Intesification

项目摘要

项目成果

Parulekar Wendy R的其他基金

相关文献

中文摘要
翻译
口咽癌(OPC)是最常见的头颈癌类型，在加拿大男性中排名第九。大多数OPC与人乳头瘤病毒(HPV)有关，预后良好。主要治疗方法通常是放射治疗。
英文摘要
Oropharyngeal carcinoma (OPC) is the most common type of head and neck cancer and ninth most common cancer in Canadian men. Most OPCs are associated with the human papilloma virus (HPV) and have a good prognosis. The primary treatment is usually radiation
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimizing head and Neck Tumour And Symptom Control in Patients Unable to Tolerate Curative (Radio)Therapy: a Phase III trial Comparing Stereotactic Body Radiation Therapy (SBRT) to Standard Palliative Radiation Treatment (ON-TASC Study)
RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials - The MMRD-GREEN trial
A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma